Cargando…
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
Ferric citrate has been reported to have the potential to reduce phosphate and increase iron availability in patients with chronic kidney disease. In the present study, we evaluated its safety and efficacy in phosphate reduction and iron supplementation in chronic kidney disease stage 3-5 requiring...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739813/ https://www.ncbi.nlm.nih.gov/pubmed/29291028 http://dx.doi.org/10.18632/oncotarget.21990 |